Default company panoramic image
Logo

Graematter, Inc.

Graematter has developed and patented an FDA-related Regulatory Intelligence System.

  • Stage Full Product Ready
  • Industry IT Services
  • Location St. Louis, MO, USA
  • Currency USD
  • Employees 6
  • Website graematter.com

Company Summary

Graematter has created a proprietary information analytics system that consolidates information from numerous FDA sources into a single database with unique search capabilities. The system helps assure that regulatory staffs will find the critical information needed to develop the shortest, lowest cost pathway to FDA approval. In addition, the Graematter System typically reduces the search time from a week to less than two hours.

Team

  • Default avatar
    Merle Symes
    CEO

    - President & CEO Ulrich Medical (spine implants)
    - President & CEO, Provenance Group (consultant and equity partner in early stage ventures)
    - VP External Technology – Bausch & Lomb
    MBA – Wharton
    BS –Chemical Engineering

  • Default avatar
    Melissa Walker
    President/CTO and Founder

    - Sr. VP Regulatory, Quality, & Compliance – Stereotaxis, Inc.
    - Exec Director, Global Regulatory Affairs – Bausch & Lomb
    - Adjunct Professor – Washington University
    - Fellow – Regulatory Affairs Professionals Society
    MS Zoology, BS Biology & Animal Science – East Texas State University

  • Default avatar
    Peggy Stohr
    CFO

    - CFO EndoStim and Pulse Therapeutics
    - CFO Yurbuds
    - VP Administration & Controller – Stereotaxis, Inc.
    CPA
    MBA – Washington University MS & BS – Accounting

Advisors

  • Default avatar
    Andrew Hoyne - Polsinelli
    Lawyer
    Unconfirmed
    Default avatar
    Stone Carlie
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    BioGenerator
    Unconfirmed
    Default avatar
    Missouri Technology Corporation
    Unconfirmed
    Default avatar
    St. Louis County Helix Fund
    Unconfirmed